Annual Accounts Payable
$5.60 M
+$1.50 M+36.59%
31 December 2023
Summary:
United Therapeutics annual accounts payable is currently $5.60 million, with the most recent change of +$1.50 million (+36.59%) on 31 December 2023. During the last 3 years, it has risen by +$1.80 million (+47.37%). UTHR annual accounts payable is now -88.15% below its all-time high of $47.26 million, reached on 31 December 2011.UTHR Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Accounts Payable
N/A
30 September 2024
Summary:
United Therapeutics quarterly accounts payable is not available.UTHR Quarterly Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
UTHR Accounts Payable Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | - | - |
| 3 y3 years | +47.4% | - |
| 5 y5 years | -43.4% | - |
UTHR Accounts Payable High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | at high | +47.4% | ||
| 5 y | 5 years | -43.4% | +47.4% | ||
| alltime | all time | -88.2% | +229.4% |
United Therapeutics Accounts Payable History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2023 | $5.60 M(+36.6%) | $5.60 M(+36.6%) |
| Dec 2022 | $4.10 M(+7.9%) | $4.10 M(+7.9%) |
| Dec 2021 | $3.80 M(-7.3%) | $3.80 M(-7.3%) |
| Dec 2020 | $4.10 M(-58.6%) | $4.10 M(-58.6%) |
| Dec 2019 | $9.90 M(-57.1%) | $9.90 M(-57.1%) |
| Dec 2018 | $23.10 M(+175.0%) | $23.10 M(+175.0%) |
| Dec 2017 | $8.40 M(+3.7%) | $8.40 M(+3.7%) |
| Dec 2016 | $8.10 M(+8.0%) | $8.10 M(+8.0%) |
| Dec 2015 | $7.50 M(+7.2%) | $7.50 M(+7.2%) |
| Dec 2014 | $7.00 M(+4.3%) | $7.00 M(+4.3%) |
| Dec 2013 | $6.71 M(-34.3%) | $6.71 M(-28.5%) |
| June 2013 | - | $9.38 M(-8.0%) |
| Mar 2013 | - | $10.19 M(-0.1%) |
| Dec 2012 | $10.20 M(-78.4%) | $10.20 M(+0.7%) |
| Sept 2012 | - | $10.13 M(+16.5%) |
| June 2012 | - | $8.70 M(+4.3%) |
| Mar 2012 | - | $8.34 M(-82.4%) |
| Dec 2011 | $47.26 M(+192.7%) | $47.26 M(+174.0%) |
| Sept 2011 | - | $17.24 M(+0.9%) |
| June 2011 | - | $17.08 M(+70.2%) |
| Mar 2011 | - | $10.04 M(-37.8%) |
| Dec 2010 | $16.15 M(-13.9%) | $16.15 M(+42.9%) |
| Sept 2010 | - | $11.30 M(+20.8%) |
| June 2010 | - | $9.35 M(+42.7%) |
| Mar 2010 | - | $6.55 M(-65.1%) |
| Dec 2009 | $18.75 M(-7.8%) | $18.75 M(+6.0%) |
| Sept 2009 | - | $17.69 M(-10.2%) |
| June 2009 | - | $19.70 M(+87.4%) |
| Mar 2009 | - | $10.51 M(-48.3%) |
| Dec 2008 | $20.33 M(+916.7%) | $20.33 M(+26.2%) |
| Sept 2008 | - | $16.11 M(+9.1%) |
| June 2008 | - | $14.77 M(-10.3%) |
| Mar 2008 | - | $16.48 M(+723.8%) |
| Dec 2007 | $2.00 M | $2.00 M(-85.7%) |
| Sept 2007 | - | $13.99 M(+174.6%) |
| Date | Annual | Quarterly |
|---|---|---|
| June 2007 | - | $5.10 M(+2.6%) |
| Mar 2007 | - | $4.97 M(+60.6%) |
| Dec 2006 | $3.09 M(-22.3%) | $3.09 M(-15.2%) |
| Sept 2006 | - | $3.65 M(-17.1%) |
| June 2006 | - | $4.40 M(-5.8%) |
| Mar 2006 | - | $4.67 M(+17.4%) |
| Dec 2005 | $3.98 M(-35.0%) | $3.98 M(-2.0%) |
| Sept 2005 | - | $4.06 M(+4.7%) |
| June 2005 | - | $3.88 M(+27.0%) |
| Mar 2005 | - | $3.06 M(-50.1%) |
| Dec 2004 | $6.13 M(+41.6%) | $6.13 M(+130.3%) |
| Sept 2004 | - | $2.66 M(+0.7%) |
| June 2004 | - | $2.64 M(-20.8%) |
| Mar 2004 | - | $3.34 M(-22.8%) |
| Dec 2003 | $4.33 M(+44.8%) | $4.33 M(-2.0%) |
| Sept 2003 | - | $4.41 M(+44.4%) |
| June 2003 | - | $3.06 M(+8.8%) |
| Mar 2003 | - | $2.81 M(-6.0%) |
| Dec 2002 | $2.99 M(-55.2%) | $2.99 M(-23.8%) |
| Sept 2002 | - | $3.92 M(-33.9%) |
| June 2002 | - | $5.93 M(+73.1%) |
| Mar 2002 | - | $3.43 M(-48.6%) |
| Dec 2001 | $6.67 M(+12.0%) | $6.67 M(+28.9%) |
| Sept 2001 | - | $5.17 M(-15.2%) |
| June 2001 | - | $6.10 M(-12.4%) |
| Mar 2001 | - | $6.96 M(+16.9%) |
| Dec 2000 | $5.95 M(+158.8%) | $5.95 M(+78.8%) |
| Sept 2000 | - | $3.33 M(-0.4%) |
| June 2000 | - | $3.34 M(+16.2%) |
| Mar 2000 | - | $2.88 M(+25.1%) |
| Dec 1999 | $2.30 M(+35.3%) | $2.30 M(+4.5%) |
| Sept 1999 | - | $2.20 M(+214.3%) |
| June 1999 | - | $700.00 K(-58.8%) |
| Mar 1999 | - | $1.70 M |
| Dec 1998 | $1.70 M | - |
FAQ
- What is United Therapeutics annual accounts payable?
- What is the all time high annual accounts payable for United Therapeutics?
- What is the all time high quarterly accounts payable for United Therapeutics?
What is United Therapeutics annual accounts payable?
The current annual accounts payable of UTHR is $5.60 M
What is the all time high annual accounts payable for United Therapeutics?
United Therapeutics all-time high annual accounts payable is $47.26 M
What is the all time high quarterly accounts payable for United Therapeutics?
United Therapeutics all-time high quarterly accounts payable is $47.26 M